From Evidence to Enterprise Value: Communicating HEOR's Value to Executive Leadership

About this session

Sponsored by the ISPOR Partnership Group Purpose: To explore how HEOR leaders can effectively position evidence as a strategic business asset and communicate its value to executive decision-makers. Through practical examples and executive perspectives, the panel will examine how HEOR informs enterprise priorities, influences critical business decisions, and creates organizational value.

Speakers

• 

  Jan E Hansen

  Sanofi

  Moderator

• 

  Craig Roberts

  Merck

  Panelist

• RM

  Russ Montgomery

  GSK US

  Panelist

• CP

  Clark Paramore

  Biogen

  Panelist